Cargando…

Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells

The generation of induced pluripotent stem cells (iPSCs) has opened up a new scientific frontier in medicine. This technology has made it possible to obtain pluripotent stem cells from individuals with genetic disorders. Because iPSCs carry the identical genetic anomalies related to those disorders,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Atsushi, Yuasa, Shinsuke, Node, Koichi, Fukuda, Keiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581278/ https://www.ncbi.nlm.nih.gov/pubmed/26274955 http://dx.doi.org/10.3390/ijms160818894

Ejemplares similares

Induced Pluripotent Stem Cells in Cardiovascular Medicine
por: Egashira, Toru, et al.
Publicado: (2011)

Induced Pluripotent Stem Cell-Based Drug Screening by Use of Artificial Intelligence
por: Kusumoto, Dai, et al.
Publicado: (2022)

Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions
por: Kishino, Yoshikazu, et al.
Publicado: (2015)

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: Tanaka, Atsushi, et al.
Publicado: (2014)

Editorial: Induced Pluripotent Stem Cell-Based Disease Modeling and Drug Discovery: Can We Recapitulate Cardiovascular Disease on a Culture Dish?
por: Yuasa, Shinsuke, et al.
Publicado: (2022)

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
por: Mishima, Takayasu, et al.
Publicado: (2018)

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Automated Deep Learning-Based System to Identify Endothelial Cells Derived from Induced Pluripotent Stem Cells
por: Kusumoto, Dai, et al.
Publicado: (2018)

Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels
por: Kodaira, Masaki, et al.
Publicado: (2015)

Generation and Characterization of Functional Cardiomyocytes Derived from Human T Cell-Derived Induced Pluripotent Stem Cells
por: Seki, Tomohisa, et al.
Publicado: (2014)

Derivation of Transgene-Free Human Induced Pluripotent Stem Cells from Human Peripheral T Cells in Defined Culture Conditions
por: Kishino, Yoshikazu, et al.
Publicado: (2014)

E-Cadherin-Coated Plates Maintain Pluripotent ES Cells without Colony Formation
por: Nagaoka, Masato, et al.
Publicado: (2006)

Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?
por: Tanaka, Atsushi, et al.
Publicado: (2017)

How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists
por: Sawami, Kosuke, et al.
Publicado: (2022)

Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Human induced pluripotent stem cell for modeling cardiovascular diseases
por: Liang, Ping, et al.
Publicado: (2014)

H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells
por: Kunitomi, Akira, et al.
Publicado: (2016)

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem Cells
por: Li, Hong, et al.
Publicado: (2018)

Psychological disturbances and their association with sleep disturbances in patients admitted for cardiovascular diseases
por: Matsuda, Risa, et al.
Publicado: (2021)

SPEG, an Indispensable Kinase of SERCA2a for Calcium Homeostasis
por: Kusumoto, Dai, et al.
Publicado: (2019)

Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
por: Tokuyama, Takeshi, et al.
Publicado: (2021)

Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
por: Paik, David T., et al.
Publicado: (2020)

Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
por: Oh, Yingzi, et al.
Publicado: (2012)

Urine-Derived Induced Pluripotent Stem Cells in Cardiovascular Disease
por: Huang, Ping, et al.
Publicado: (2020)

Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
por: Sharma, Arun, et al.
Publicado: (2013)

Manipulation of Pluripotent Stem Cell Metabolism for Clinical Application
por: Tohyama, Shugo, et al.
Publicado: (2017)

Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
por: Kim, Huensuk, et al.
Publicado: (2018)

Prevalence and temporal trends of prostate diseases among inpatients with cardiovascular disease: a nationwide real-world database survey in Japan
por: Kaneta, Kohei, et al.
Publicado: (2023)

Toward the realization of cardiac regenerative medicine using pluripotent stem cells
por: Kishino, Yoshikazu, et al.
Publicado: (2020)

Modeling Retinal Degeneration Using Patient-Specific Induced Pluripotent Stem Cells
por: Jin, Zi-Bing, et al.
Publicado: (2011)

Scaffold-Free Tubular Engineered Heart Tissue From Human Induced Pluripotent Stem Cells Using Bio-3D Printing Technology in vivo
por: Kawai, Yujiro, et al.
Publicado: (2022)

Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
por: Byers, Blake, et al.
Publicado: (2012)

Using induced pluripotent stem cells for modeling Parkinson’s disease
por: Ke, Minjing, et al.
Publicado: (2019)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

Modeling aortic diseases using induced pluripotent stem cells
por: Zhu, Kai, et al.
Publicado: (2020)

Disease-specific pluripotent stem cells
por: Kang, Hoon-Chul
Publicado: (2010)

Prediction of Stroke After Cardiac Catheterization: No Reason, No Stroke
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2t8bf1dneajac3ibvc6hflejha